{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T22:47:29Z","timestamp":1774046849355,"version":"3.50.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,5,31]]},"DOI":"10.7759\/cureus.39789","type":"journal-article","created":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T18:56:58Z","timestamp":1685559418000},"source":"Crossref","is-referenced-by-count":9,"title":["Antitumor Activity of Luteolin Against Ehrlich Solid Carcinoma in Rats via Blocking Wnt\/\u03b2-Catenin\/SMAD4 Pathway"],"prefix":"10.7759","author":[{"given":"Heba","family":"Aljohani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed E","family":"Khodier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed M","family":"Al-Gayyar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21551","article-title":"Cancer statistics, 2019","volume":"69","author":"Siegel RL","year":"2019","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019, 69:7-34. 10.3322\/caac.21551","journal-title":"CA Cancer J Clin"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung H","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021, 71:209-49. 10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2016.08.009","article-title":"Solid Ehrlich carcinoma reproduces functional and biological characteristics of cancer cachexia","volume":"162","author":"Frajacomo FT","year":"2016","unstructured":"Frajacomo FT, de Souza Padilha C, Marinello PC, Guarnier FA, Cecchini R, Duarte JA, Deminice R. Solid Ehrlich carcinoma reproduces functional and biological characteristics of cancer cachexia. Life Sci. 2016, 162:47-53. 10.1016\/j.lfs.2016.08.009","journal-title":"Life Sci"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232314957","article-title":"Evidence for multilevel chemopreventive activities of natural phenols from functional genomic studies of curcumin, resveratrol, genistein, quercetin, and luteolin","volume":"23","author":"Huminiecki L","year":"2022","unstructured":"Huminiecki L. Evidence for multilevel chemopreventive activities of natural phenols from functional genomic studies of curcumin, resveratrol, genistein, quercetin, and luteolin. Int J Mol Sci. 2022, 23:10.3390\/ijms232314957","journal-title":"Int J Mol Sci"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.4103\/jcrt.JCRT_1116_19","article-title":"Pro-apoptotic and anti-neoplastic impact of luteolin on solid Ehrlich carcinoma.bearing mice exposed to gamma radiation","volume":"16","author":"Azab KS","year":"2020","unstructured":"Azab KS, El Fatih NM, El Tawill G, El Bakary NM. Pro-apoptotic and anti-neoplastic impact of luteolin on solid Ehrlich carcinoma.bearing mice exposed to gamma radiation. J Cancer Res Ther. 2020, 16:1506-16. 10.4103\/jcrt.JCRT_1116_19","journal-title":"J Cancer Res Ther"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2019.108740","article-title":"Luteolin and 5-flurouracil act synergistically to induce cellular weapons in experimentally induced Solid Ehrlich Carcinoma: Realistic role of P53; a guardian fights in a cellular battle","volume":"310","author":"Soliman NA","year":"2019","unstructured":"Soliman NA, Abd-Ellatif RN, ELaadany AA, Shalaby SM, Bedeer AE. Luteolin and 5-flurouracil act synergistically to induce cellular weapons in experimentally induced Solid Ehrlich Carcinoma: Realistic role of P53; a guardian fights in a cellular battle. Chem Biol Interact. 2019, 310:108740. 10.1016\/j.cbi.2019.108740","journal-title":"Chem Biol Interact"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s11010-023-04746-8","article-title":"Therapeutic effects of genistein in experimentally induced ulcerative colitis in rats via affecting mitochondrial biogenesis","author":"Alharbi TS","year":"2023","unstructured":"Alharbi TS, Alshammari ZS, Alanzi ZN, Althobaiti F, Elewa MA, Hashem KS, Al-Gayyar MM. Therapeutic effects of genistein in experimentally induced ulcerative colitis in rats via affecting mitochondrial biogenesis. Mol Cell Biochem. 2023, 10.1007\/s11010-023-04746-8","journal-title":"Mol Cell Biochem"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.110138","article-title":"Curative effects of crocin in ulcerative colitis via modulating apoptosis and inflammation","volume":"118","author":"Albalawi GA","year":"2023","unstructured":"Albalawi GA, Albalawi MZ, Alsubaie KT, Albalawi AZ, Elewa MA, Hashem KS, Al-Gayyar MM. Curative effects of crocin in ulcerative colitis via modulating apoptosis and inflammation. Int Immunopharmacol. 2023, 118:110138. 10.1016\/j.intimp.2023.110138","journal-title":"Int Immunopharmacol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.32519","article-title":"Evaluating the anticancer activity of blocking TNF type 1 receptors in thioacetamide-induced hepatocellular carcinoma in a rat model","volume":"14","author":"Bagalagel A","year":"2022","unstructured":"Bagalagel A, Diri R, Noor A, Almasri D, Bakhsh H, Kutbi HI, Al-Gayyar MM. Evaluating the anticancer activity of blocking TNF type 1 receptors in thioacetamide-induced hepatocellular carcinoma in a rat model. Cureus. 2022, 14:e32519. 10.7759\/cureus.32519","journal-title":"Cureus"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-022-02269-5","article-title":"[1,2,4] Triazolo [3,4-a]isoquinoline chalcone derivative exhibits anticancer activity via induction of oxidative stress, DNA damage, and apoptosis in Ehrlich solid carcinoma-bearing mice","volume":"395","author":"WalyEldeen AA","year":"2022","unstructured":"WalyEldeen AA, El-Shorbagy HM, Hassaneen HM, Abdelhamid IA, Sabet S, Ibrahim SA. [1,2,4] Triazolo [3,4-a]isoquinoline chalcone derivative exhibits anticancer activity via induction of oxidative stress, DNA damage, and apoptosis in Ehrlich solid carcinoma-bearing mice. Naunyn Schmiedebergs Arch Pharmacol. 2022, 395:1225-38. 10.1007\/s00210-022-02269-5","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.111216","article-title":"Therapeutic effects of blocking \u03b2-catenin against hepatocellular carcinoma-induced activation of inflammation, fibrosis and tumor invasion","volume":"135","author":"Hassan HM","year":"2021","unstructured":"Hassan HM, El-Kannishy SM, Alattar A, Alshaman R, Hamdan AM, Al-Gayyar MM. Therapeutic effects of blocking \u03b2-catenin against hepatocellular carcinoma-induced activation of inflammation, fibrosis and tumor invasion. Biomed Pharmacother. 2021, 135:111216. 10.1016\/j.biopha.2021.111216","journal-title":"Biomed Pharmacother"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-26761-2","article-title":"Luteolin attenuates Wnt signaling via upregulation of FZD6 to suppress prostate cancer stemness revealed by comparative proteomics","volume":"8","author":"Han K","year":"2018","unstructured":"Han K, Lang T, Zhang Z, et al.. Luteolin attenuates Wnt signaling via upregulation of FZD6 to suppress prostate cancer stemness revealed by comparative proteomics. Sci Rep. 2018, 8:8537. 10.1038\/s41598-018-26761-2","journal-title":"Sci Rep"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.7314\/apjcp.2014.15.14.5501","article-title":"Luteolin, a bioflavonoid inhibits colorectal cancer through modulation of multiple signaling pathways: a review","volume":"15","author":"Pandurangan AK","year":"2014","unstructured":"Pandurangan AK, Esa NM. Luteolin, a bioflavonoid inhibits colorectal cancer through modulation of multiple signaling pathways: a review. Asian Pac J Cancer Prev. 2014, 15:5501-8. 10.7314\/apjcp.2014.15.14.5501","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1080\/14756366.2023.2185761","article-title":"WRH-2412 alleviates the progression of hepatocellular carcinoma through regulation of TGF-\u03b2\/\u03b2-catenin\/\u03b1-SMA pathway","volume":"38","author":"Elewa MA","year":"2023","unstructured":"Elewa MA, Eldehna WM, Hamdan AM, et al.. WRH-2412 alleviates the progression of hepatocellular carcinoma through regulation of TGF-\u03b2\/\u03b2-catenin\/\u03b1-SMA pathway. J Enzyme Inhib Med Chem. 2023, 38:2185761. 10.1080\/14756366.2023.2185761","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3001538","article-title":"PTEN deficiency in endometrioid endometrial adenocarcinomas predicts sensitivity to PARP inhibitors","volume":"2","author":"Dedes KJ","year":"2010","unstructured":"Dedes KJ, Wetterskog D, Mendes-Pereira AM, et al.. PTEN deficiency in endometrioid endometrial adenocarcinomas predicts sensitivity to PARP inhibitors. Sci Transl Med. 2010, 2:53ra75. 10.1126\/scitranslmed.3001538","journal-title":"Sci Transl Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232214383","article-title":"E-cadherin expression in relation to clinicopathological parameters and survival of patients with epithelial ovarian cancer","volume":"23","author":"Kielbik M","year":"2022","unstructured":"Kielbik M, Szulc-Kielbik I, Klink M. E-cadherin expression in relation to clinicopathological parameters and survival of patients with epithelial ovarian cancer. Int J Mol Sci. 2022, 23:10.3390\/ijms232214383","journal-title":"Int J Mol Sci"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21207624","article-title":"Role of cadherins in cancer: a review","volume":"21","author":"Kaszak I","year":"2020","unstructured":"Kaszak I, Witkowska-Pi\u0142aszewicz O, Niewiadomska Z, Dworecka-Kaszak B, Ngosa Toka F, Jurka P. Role of cadherins in cancer: a review. Int J Mol Sci. 2020, 21:10.3390\/ijms21207624","journal-title":"Int J Mol Sci"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.00989","article-title":"Cadherin signaling in cancer: its functions and role as a therapeutic target","volume":"9","author":"Yu W","year":"2019","unstructured":"Yu W, Yang L, Li T, Zhang Y. Cadherin signaling in cancer: its functions and role as a therapeutic target. Front Oncol. 2019, 9:989. 10.3389\/fonc.2019.00989","journal-title":"Front Oncol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-09-0191","article-title":"Luteolin inhibits invasion of prostate cancer PC3 cells through E-cadherin","volume":"8","author":"Zhou Q","year":"2009","unstructured":"Zhou Q, Yan B, Hu X, Li XB, Zhang J, Fang J. Luteolin inhibits invasion of prostate cancer PC3 cells through E-cadherin. Mol Cancer Ther. 2009, 8:1684-91. 10.1158\/1535-7163.MCT-09-0191","journal-title":"Mol Cancer Ther"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/158838-antitumor-activity-of-luteolin-against-ehrlich-solid-carcinoma-in-rats-via-blocking-wnt-cateninsmad4-pathway","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:04:39Z","timestamp":1707509079000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/158838-antitumor-activity-of-luteolin-against-ehrlich-solid-carcinoma-in-rats-via-blocking-wnt-cateninsmad4-pathway"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,31]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.39789","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5,31]]}}}